Becker's Healthcare October 7, 2024
The FDA has recently approved two new tests for colorectal cancer screenings. These tests are less invasive, and may encourage more patients to seek care.
Here are seven things to know about new colonoscopy alternatives:
1. At the beginning of October, the FDA approved the Cologuard Plus test, a next-generation, multitarget stool DNA test approved for patients at an average risk for colorectal cancer.
2. In a trial of 19,000 patients, ]Cologuard Plus test demonstrated 95% overall cancer sensitivity and 43% sensitivity for advanced precancerous lesions at 94% specificity.
3. Cologuard Plus outperformed an independent...
Today's Sponsors
Today's Sponsor